Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-hydroxybenzamides as HDAC inhibitors for the treatment of parasitic diseases

N-hydroxybenzamides as HDAC inhibitors for the treatment of parasitic diseases

US Patent 10106493 · Granted Oct 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azaindole derivatives and their use as ERK kinase inhibitors2025
Azaindole derivatives and their use as ERK kinase inhibitors2023
Azaindole derivatives and their use as ERK kinase inhibitors2023
Azaindole derivatives and their use as ERK kinase inhibitors2023
Zaindole derivatives and their use as ERK kinase inhibitors2021
Zaindole derivatives and their use as ERK kinase inhibitors2021
Analogues of temporin-SHa and uses thereof2018
Analogs of temporin-SHa and uses thereof2016
Phosphodeoxyribosyl transferase mutant enzymes and uses thereof2016
Antibacterial compounds2015
Inhibitors of cyclophilins and uses thereof2014
Method for the screening of conserved secreted proteins2014